LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Ventricular Arrhythmias Following Ibrutinib Initiation for Lymphoid Malignancies.

Photo by nci from unsplash

Ibrutinib is a new Bruton’s tyrosine kinase inhibitor associated with improvements in the outcomes of various B-cell hematologic malignancies and is now standard lifelong therapy in those without intolerance or disease… Click to show full abstract

Ibrutinib is a new Bruton’s tyrosine kinase inhibitor associated with improvements in the outcomes of various B-cell hematologic malignancies and is now standard lifelong therapy in those without intolerance or disease progression [(1)][1]. However, there is a >4-fold increased risk of incident

Keywords: initiation lymphoid; following ibrutinib; ventricular arrhythmias; ibrutinib initiation; arrhythmias following; lymphoid malignancies

Journal Title: Journal of the American College of Cardiology
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.